Exchange: NSE·Updated 04:00 PM GMT+5:30
About FDC.NSE
FDC Ltd. engages in the manufacture and sale of pharmaceutical formulations and active pharmaceutical ingredients. It operates through the following geographical segments: India, USA, and Others. The India segment manufactures and distributes pharmaceutical products, oral rehydration salts, and energy drinks across domestic markets. The USA segment handles the export and distribution of generic pharmaceutical products and formulations to North American markets. The Others segment covers international sales and exports to rest-of-the-world markets. Its therapeutic portfolio includes anti-infectives, gastrointestinals, ophthalmologicals, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, and analgesics, featuring key brands such as Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. The company was founded by Anand L. Chandavarkar on December 7, 1936, and is headquartered in Mumbai, India.